We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Genetic Diagnostics Contribute to the Risk Stratification for Major Arrhythmic Events in Pediatric Patients with Long QT Syndrome Type 1-3.
- Authors
Burkard, Tobias; Sebastian Westphal, Dominik; Markel, Franziska; Gebauer, Roman Antonin; Hessling, Gabriele; Wolf, Cordula Maria
- Abstract
Long QT syndrome (LQTS) is an inherited arrhythmic disorder associated with sudden cardiac death (SCD). This study aimed to identify the clinical and molecular genetic risk factors that contribute to major arrhythmic events (MAEs) in patients with genetically confirmed childhood onset LQTS 1--3. This study was a retrospective double-center study. An MAE was defined as the occurrence of SCD, aborted SCD, appropriate implantable cardioverter defibrillator discharge, or sustained ventricular tachycardia. During a median follow-up of 4.6 years (range 0.1--24.3 years), MAEs occurred in 18 (17.8%) of 101 patients diagnosed with LQTS at a median of 7.7 years (range 0.0--18.0 years) despite the use of beta-blockers in 91.6% of patients at the last follow-up. A multivariate analysis identified a genetic diagnosis of LQTS2 and LQTS3 and variants within the KCNH2 S5-loop-S6 pore region as independent risk factors for MAEs, independent of the QTc value or a history of syncope detected from a univariate analysis. MAEs occur frequently in childhood onset LQTS despite beta-blocker treatment. A detailed molecular genetic diagnosis can contribute to the arrhythmia risk stratification and optimize the use of preventive measures in this vulnerable patient population.
- Subjects
LONG QT syndrome; ARRHYTHMIA; CHILD patients; BRUGADA syndrome; CARDIAC arrest; VENTRICULAR tachycardia; IMPLANTABLE cardioverter-defibrillators
- Publication
Cardiogenetics, 2022, Vol 12, Issue 1, p90
- ISSN
2035-8253
- Publication type
Article
- DOI
10.3390/cardiogenetics12010009